01 / Vendor Profile
GLAXOSMITHKLINE, LLC Federal Contracts and Awards
UEI FRHTPHMZMX47 · CAGE 667E9
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $2.50B in net contract obligations to GLAXOSMITHKLINE, LLC across 763 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
GLAXOSMITHKLINE, LLC contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$40.47M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $369.55M | 181 | 11 | — |
| FY 2021 | $318.39M | 70 | 11 | −13.8% |
| FY 2022 | $1.66B | 201 | 10 | +422.6% |
| FY 2023 | $12.81M | 63 | 9 | −99.2% |
| FY 2024 | $62.73M | 152 | 11 | +389.6% |
| FY 2025 | $29.91M | 53 | 7 | −52.3% |
| FY 2026 | $40.47M | 43 | 9 | +35.3% |
04 / Federal Customers
Which federal agencies buy from GLAXOSMITHKLINE, LLC?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 2100 | $2.21B | 45 | 88.6% | |
| 7505 | $185.57M | 135 | 7.4% | |
| 97AS | $70.46M | 185 | 2.8% | |
| 3600 | $8.39M | 103 | 0.3% | |
| 7527 | $7.60M | 11 | 0.3% | |
| 1900 | $4.58M | 14 | 0.2% | |
| 7523 | $2.77M | 59 | 0.1% | |
| 1549 | $1.69M | 29 | 0.1% | |
| 7570 | $1.65M | 32 | 0.1% | |
| 1540 | $785.1K | 141 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from GLAXOSMITHKLINE, LLC?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| W58P05 | DEPT OF THE ARMY | $1.88B | 9 | 75.2% | |
| W15QKN | DEPT OF THE ARMY | $335.59M | 16 | 13.4% | |
| 75A501 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $124.07M | 126 | 5.0% | |
| SPE2DP | DEFENSE LOGISTICS AGENCY | $70.46M | 185 | 2.8% | |
| 75A503 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | $61.50M | 9 | 2.5% | |
| 75H711 | INDIAN HEALTH SERVICE | $7.60M | 11 | 0.3% | |
| 19AQMM | STATE, DEPARTMENT OF | $4.50M | 11 | 0.2% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $2.77M | 58 | 0.1% | |
| 36C261 | VETERANS AFFAIRS, DEPARTMENT OF | $1.72M | 34 | 0.1% | |
| 15F067 | FEDERAL BUREAU OF INVESTIGATION | $1.69M | 29 | 0.1% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $2.34B | 566 | 11 | 93.6% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $112.22M | 87 | 1 | 4.5% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $30.50M | 7 | 1 | 1.2% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $13.54M | 48 | 3 | 0.5% |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | $2.08M | 26 | 2 | 0.1% |
| 493120 | REFRIGERATED WAREHOUSING AND STORAGE | $687.8K | 16 | 1 | 0.0% |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | $346.6K | 8 | 4 | 0.0% |
| 339999 | ALL OTHER MISCELLANEOUS MANUFACTURING | $2.4K | 1 | 1 | 0.0% |
| 339113 | SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING | -$8.9K | 3 | 1 | 0.0% |
| 446110 | PHARMACIES AND DRUG STORES | -$10.6K | 1 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6505 | DRUGS AND BIOLOGICALS | $2.45B | 624 | 10 | 98.1% |
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $26.25M | 22 | 1 | 1.1% |
| AN14 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | $7.79M | 10 | 1 | 0.3% |
| Q517 | MEDICAL- PHARMACOLOGY | $7.30M | 17 | 3 | 0.3% |
| R799 | SUPPORT- MANAGEMENT: OTHER | $2.08M | 15 | 1 | 0.1% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $2.05M | 45 | 5 | 0.1% |
| R497 | SUPPORT- PROFESSIONAL: PERSONAL SERVICES CONTRACTS | $687.8K | 16 | 1 | 0.0% |
| 3650 | CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $48.4K | 4 | 1 | 0.0% |
| Q999 | MEDICAL- OTHER | $17.1K | 7 | 1 | 0.0% |
| Q201 | MEDICAL- GENERAL HEALTH CARE | $4.9K | 2 | 1 | 0.0% |
08 / Competition Pattern
How was GLAXOSMITHKLINE, LLC’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for GLAXOSMITHKLINE, LLC?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75A50325C00019 | Sep 25, 2026 | $18.20M | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE ASPR/ORM-SNS | 325412 | 6505 |
10 / Interpreting the Profile
How should you evaluate GLAXOSMITHKLINE, LLC as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.